Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
Add more filters










Publication year range
1.
Cancer Med ; 13(12): e7224, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38888366

ABSTRACT

BACKGROUND: Patients with DNA mismatch repair-proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC), which accounts for 85% of all CRC cases, display a poor respond to immune checkpoint inhibitors (i.e., anti-PD-1 antibodies). pMMR/MSS CRC patients with locally advanced cancers need effective combined therapies. METHODS: In this pilot study, we administered six preoperative doses of each 2-week cycle of the anti-PD-1 antibody sintilimab (at a fixed dose of 200 mg), oxaliplatin, and 5-FU/CF (mFOLFOX6) combined with five doses of bevacizumab (the number of doses was reduced to prevent surgical delays) to patients with cT4NxM0 colon or upper rectal cancers. And radical surgery was performed approximately 2 weeks after the last dose of neoadjuvant therapy. The primary endpoint was a pathologic complete response (pCR). We also evaluated major pathologic response (MPR, ≤10% residual viable tumor), radiological and pathological regression, safety, and tumor mutation burden (TMB), and tumor microenvironment (TME) characteristics. RESULTS: By the cutoff date (September 2023), 22 patients with cT4NxM0 pMMR/MSS colon or upper rectal cancers were enrolled and the median follow-up was 24.7 months (IQR: 21.1-26.1). All patients underwent R0 surgical resection without treatment-related surgical delays. pCR occurred in 12 of 22 resected tumors (54.5%) and MPR occurred in 18 of 22 (81.8%) patients. At the cutoff date, all patients were alive, and 21/22 were recurrence-free. Treatment-related adverse events of grade 3 or higher occurred in of 2/22 (9.1%) patients. Among the pCR tumors, two were found to harbor POLE mutations. The degree of pathological regression was significantly greater than that of radiological regression (p = 1.35 × 10-8). The number of CD3+/CD4+ cells in the tumor and stroma in pretreated biopsied tissues was markedly lower in pCR tumors than in non-pCR tumors (p = 0.038 and p = 0.015, respectively). CONCLUSIONS: Neoadjuvant sintilimab combined with bevacizumab and mFOLFOX6 was associated with few side effects, did not delay surgery, and led to pCR and non-pCR in 54.5% and 81.8% of the cases, respectively. Downregulation of CD3/CD4 expression in the tumor and stroma is related to pCR. However, the molecular mechanisms underlying PD-1 blockade-enhanced targeted chemotherapy require further investigation.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols , Bevacizumab , Colorectal Neoplasms , Fluorouracil , Immune Checkpoint Inhibitors , Humans , Male , Female , Middle Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Aged , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Fluorouracil/therapeutic use , Fluorouracil/administration & dosage , Immune Checkpoint Inhibitors/therapeutic use , Immune Checkpoint Inhibitors/adverse effects , Pilot Projects , Bevacizumab/therapeutic use , Bevacizumab/administration & dosage , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Monoclonal, Humanized/administration & dosage , Antibodies, Monoclonal, Humanized/adverse effects , Leucovorin/therapeutic use , Leucovorin/administration & dosage , DNA Mismatch Repair , Adult , Microsatellite Instability , Oxaliplatin/therapeutic use , Oxaliplatin/administration & dosage , Neoadjuvant Therapy/methods , Tumor Microenvironment/immunology , Organoplatinum Compounds/therapeutic use , Organoplatinum Compounds/administration & dosage , Programmed Cell Death 1 Receptor/antagonists & inhibitors , Treatment Outcome
2.
Cell Mol Life Sci ; 81(1): 155, 2024 Mar 28.
Article in English | MEDLINE | ID: mdl-38538986

ABSTRACT

The prostate is a vital accessory gonad in the mammalian male reproductive system. With the ever-increasing proportion of the population over 60 years of age worldwide, the incidence of prostate diseases, such as benign prostatic hyperplasia (BPH) and prostate cancer (PCa), is on the rise and is gradually becoming a significant medical problem globally. The notch signaling pathway is essential in regulating prostate early development. However, the potential regulatory mechanism of Notch signaling in prostatic enlargement and hyperplasia remains unclear. In this study, we proved that overactivation of Notch1 signaling in mouse prostatic epithelial cells (OEx) led to prostatic enlargement via enhancing proliferation and inhibiting apoptosis of prostatic epithelial cells. Further study showed that N1ICD/RBPJ directly up-regulated the androgen receptor (AR) and enhanced prostatic sensitivity to androgens. Hyper-proliferation was not found in orchidectomized OEx mice without androgen supply but was observed after Dihydrotestosterone (DHT) supplementation. Our data showed that the number of mitochondrion in prostatic epithelial cells of OEx mice was increased, but the mitochondrial function was impaired, and the essential activity of the mitochondrial respiratory electron transport chain was significantly weakened. Disordered mitochondrial number and metabolic function further resulted in excessive accumulation of reactive oxygen species (ROS). Importantly, anti-oxidant N-Acetyl-L-Cysteine (NAC) therapy could alleviate prostatic hyperplasia caused by the over-activation of Notch1 signaling. Furthermore, we observed the incremental Notch signaling activity in progenitor-like club cells in the scRNA-seq data set of human BPH patients. Moreover, the increased number of TROP2+ progenitors and Club cells was also confirmed in our OEx mice. In conclusion, our study revealed that over-activated Notch1 signaling induces prostatic enlargement by increasing androgen receptor sensitivity, disrupting cellular mitochondrial metabolism, increasing ROS, and a higher number of progenitor cells, all of which can be effectively rescued by NAC treatment.


Subject(s)
Prostatic Hyperplasia , Animals , Humans , Male , Mice , Androgens/metabolism , Mammals/metabolism , Mitochondria/metabolism , Prostate/metabolism , Prostatic Hyperplasia/metabolism , Reactive Oxygen Species/metabolism , Receptors, Androgen/genetics , Receptors, Androgen/metabolism , Signal Transduction
3.
Aging Dis ; 2024 Jan 11.
Article in English | MEDLINE | ID: mdl-38300633

ABSTRACT

Metabolic reprogramming is a defining hallmark of cancer metastasis, warranting thorough exploration. The tumor-promoting function of the "Warburg Effect", marked by escalated glycolysis and restrained mitochondrial activity, is widely acknowledged. Yet, the functional significance of mitochondria-mediated oxidative phosphorylation (OXPHOS) during metastasis remains controversial. Circulating tumor cells (CTCs) are considered metastatic precursors that detach from primary or secondary sites and harbor the potential to seed distant metastases through hematogenous dissemination. A comprehensive metabolic characterization of CTCs faces formidable obstacles, including the isolation of these rare cells from billions of blood cells, coupled with the complexities of ex vivo-culturing of CTC lines or the establishment of CTC-derived xenograft models (CDX). This review summarized the role of the "Warburg Effect" in both tumorigenesis and CTC-mediated metastasis. Intriguingly, bioinformatic analysis of single-CTC transcriptomic studies unveils a potential OXPHOS dominance over Glycolysis signature genes across several important cancer types. From these observations, we postulate a potential "Anti-Warburg Effect" (AWE) in CTCs-a metabolic shift bridging primary tumors and metastases. The observed AWE could be clinically important as they are significantly correlated with therapeutic response in melanoma and prostate patients. Thus, unraveling dynamic metabolic regulations within CTC populations might reveal an additional layer of regulatory complexities of cancer metastasis, providing an avenue for innovative anti-metastasis therapies.

4.
Proc Natl Acad Sci U S A ; 120(5): e2214684120, 2023 01 31.
Article in English | MEDLINE | ID: mdl-36693099

ABSTRACT

Embryo implantation, a crucial step in human reproduction, is tightly controlled by estrogen and progesterone (P4) via estrogen receptor alpha and progesterone receptor (PGR), respectively. Here, we report that N6-methyladenosine (m6A), the most abundant mRNA modification in eukaryotes, plays an essential role in embryo implantation through the maintenance of P4 signaling. Conditional deletion of methyltransferase-like 3 (Mettl3), encoding the m6A writer METTL3, in the female reproductive tract using a Cre mouse line with Pgr promoter (Pgr-Cre) resulted in complete implantation failure due to pre-implantation embryo loss and defective uterine receptivity. Moreover, the uterus of Mettl3 null mice failed to respond to artificial decidualization. We further found that Mettl3 deletion was accompanied by a marked decrease in PGR protein expression. Mechanistically, we found that Pgr mRNA is a direct target for METTL3-mediated m6A modification. A luciferase assay revealed that the m6A modification in the 5' untranslated region (5'-UTR) of Pgr mRNA enhances PGR protein translation efficiency in a YTHDF1-dependent manner. Finally, we demonstrated that METTL3 is required for human endometrial stromal cell decidualization in vitro and that the METTL3-PGR axis is conserved between mice and humans. In summary, this study provides evidence that METTL3 is essential for normal P4 signaling during embryo implantation via m6A-mediated translation control of Pgr mRNA.


Subject(s)
Progesterone , Receptors, Progesterone , Female , Mice , Humans , Animals , Progesterone/metabolism , Receptors, Progesterone/genetics , Receptors, Progesterone/metabolism , Embryo Implantation/genetics , Uterus/metabolism , Methyltransferases/genetics , Methyltransferases/metabolism , Mice, Knockout , RNA, Messenger/metabolism
5.
Front Cell Dev Biol ; 10: 796358, 2022.
Article in English | MEDLINE | ID: mdl-35602598

ABSTRACT

Litter size is one of the most economically important traits in commercial pig farming. It has been estimated that approximately 30% of porcine embryos are lost during the peri-implantation period. Despite rapid advances over recent years, the molecular mechanism underlying embryo implantation in pigs remains poorly understood. In this study, the conceptus together with a small amount of its surrounding endometrial tissues at the implantation site was collected and subjected to single-cell RNA-seq using the 10x platform. Because embryo and maternal endometrium were genetically different, we successfully dissected embryonic cells from maternal endometrial cells in the data according to single nucleotide polymorphism information captured by single-cell RNA-seq. Undoubtedly, the interaction between trophoblast cells and uterine epithelial cells represents the key mechanism of embryo implantation. Using the CellChat tool, we revealed cell-cell communications between these 2 cell types in terms of secreted signaling, ECM-receptor interaction and cell-cell contact. Additionally, by analyzing the non-pregnant endometrium as control, we were able to identify global gene expression changes associated with embryo implantation in each cell type. Our data provide a valuable resource for deciphering the molecular mechanism of embryo implantation in pigs.

6.
Physiol Genomics ; 54(6): 187-195, 2022 06 01.
Article in English | MEDLINE | ID: mdl-35468005

ABSTRACT

In most mammalian species, the testis descends from the abdomen into the scrotum during fetal or neonatal life. The failure of testicular descent, a pathological condition known as cryptorchidism, has long been the subject of scientific interest in a wide range of fields, including medicine, developmental biology, and evolutionary biology. In this study, we analyzed global gene expression changes associated with experimental cryptorchidism in mice by using RNA-seq. A total of 453 differentially expressed genes were identified, of which 236 genes were upregulated, and 217 genes were downregulated. Gene ontology, pathway, and gene network analysis highlighted the activation of inflammatory response in experimental cryptorchidism. By examining the promoter regions of differentially expressed genes, we identified 12 causal transcription factors. In addition, we also induced experimental cryptorchidism in two cynomolgus monkeys and performed RNA-seq. A cross-species comparison was performed at the gene expression level. Our study provides a valuable resource for further understanding the molecular mechanisms of cryptorchidism in mammals.


Subject(s)
Cryptorchidism , Animals , Cryptorchidism/genetics , Cryptorchidism/metabolism , Cryptorchidism/pathology , Gene Expression Profiling , Humans , Macaca fascicularis/genetics , Male , Mammals/genetics , Testis/metabolism , Transcriptome/genetics
7.
Cell Biosci ; 12(1): 13, 2022 Feb 05.
Article in English | MEDLINE | ID: mdl-35123575

ABSTRACT

BACKGROUND: Embryo implantation into the uterus is a crucial step for human reproduction. A hypothesis has been proposed that the molecular circuit invented by trophoblasts for invasive embryo implantation during evolution might be misused by cancer cells to promote malignancy. Unfortunately, our current understanding of the molecular mechanism underlying embryo implantation is far from complete. RESULTS: Here we used the mouse as an animal model and generated a single-cell transcriptomic atlas of the embryo implantation site of mouse uterus at the invasion phase of embryo implantation on gestational day 6. We revealed 23 distinct cell clusters, including 5 stromal cell clusters, 2 epithelial cell clusters, 1 smooth muscle cell cluster, 2 pericyte clusters, 4 endothelial cell clusters, and 9 immune cell clusters. Through data analysis, we identified differentially expression changes in all uterine cell types upon embryo implantation. By integrated with single-cell RNA-seq data from E5.5 embryos, we predicted cell-cell crosstalk between trophoblasts and uterine cell types. CONCLUSIONS: Our study provides a valuable resource for understanding of the molecular mechanism of embryo implantation.

8.
ACS Chem Neurosci ; 13(3): 390-405, 2022 02 02.
Article in English | MEDLINE | ID: mdl-35050567

ABSTRACT

To realize PDE4 inhibitors with good developmental potentiality for the treatment of dementia, structure-based optimizations of lead compound FCPR03 resulted in novel aminophenylketones 9c and 9H with low nanomolar potency, which displayed comparable activity to rolipram, satisfactory bioavailability (F% = 36.92 and 42.96% respectively), and good blood-brain barrier (BBB) permeability switching from the cyclopropyl methoxy group to the cyclopropyl methylamine and the amide group to the corresponding ketone. Emetogenicity evaluation on a combined ketamine/xylazine anesthesia mice alternative model demonstrated that 9H displays no emetogenicity even at an oral dose of 5 mg/kg. In contrast, rolipram and roflumilast displayed emetogenicity at an oral dose of 0.5 mg/kg. In acute toxicological evaluation, 9H showed no obvious toxicological effect on mice when administered at oral doses below 625 mg/kg. Further investigations revealed that 9H improves the memory and cognitive impairment of Alzheimer's disease (AD) model mice induced by Aß25-35.


Subject(s)
Phosphodiesterase 4 Inhibitors , Animals , Biological Availability , Cyclic Nucleotide Phosphodiesterases, Type 4/metabolism , Disease Models, Animal , Mice , Phosphodiesterase 4 Inhibitors/pharmacology , Phosphodiesterase 4 Inhibitors/therapeutic use , Rolipram/pharmacology , Spatial Memory
9.
Int J Mol Sci ; 22(14)2021 Jul 19.
Article in English | MEDLINE | ID: mdl-34299317

ABSTRACT

Decidualization is a crucial step for human reproduction, which is a prerequisite for embryo implantation, placentation and pregnancy maintenance. Despite rapid advances over recent years, the molecular mechanism underlying decidualization remains poorly understood. Here, we used the mouse as an animal model and generated a single-cell transcriptomic atlas of a mouse uterus during decidualization. By analyzing the undecidualized inter-implantation site of the uterus as a control, we were able to identify global gene expression changes associated with decidualization in each cell type. Additionally, we identified intercellular crosstalk between decidual cells and niche cells, including immune cells, endothelial cells and trophoblast cells. Our data provide a valuable resource for deciphering the molecular mechanism underlying decidualization.


Subject(s)
Decidua/cytology , Decidua/metabolism , Uterus/cytology , Uterus/metabolism , Animals , Cell Communication/genetics , Cell Communication/immunology , Decidua/immunology , Embryo Implantation/genetics , Endothelial Cells/cytology , Endothelial Cells/metabolism , Female , Humans , Mice , Models, Animal , Placentation/genetics , Pregnancy , Pregnancy Maintenance/genetics , RNA-Seq , Single-Cell Analysis , Stromal Cells/cytology , Stromal Cells/metabolism , Transcriptome , Trophoblasts/cytology , Trophoblasts/metabolism , Uterus/immunology
10.
Int J Mol Sci ; 22(10)2021 May 13.
Article in English | MEDLINE | ID: mdl-34068395

ABSTRACT

As a crucial step for human reproduction, embryo implantation is a low-efficiency process. Despite rapid advances in recent years, the molecular mechanism underlying embryo implantation remains poorly understood. Here, we used the mouse as an animal model and generated a single-cell transcriptomic atlas of embryo implantation sites. By analyzing inter-implantation sites of the uterus as control, we were able to identify global gene expression changes associated with embryo implantation in each cell type. Additionally, we predicted signaling interactions between uterine luminal epithelial cells and mural trophectoderm of blastocysts, which represent the key mechanism of embryo implantation. We also predicted signaling interactions between uterine epithelial-stromal crosstalk at implantation sites, which are crucial for post-implantation development. Our data provide a valuable resource for deciphering the molecular mechanism underlying embryo implantation.


Subject(s)
Blastocyst/physiology , Cell Communication , Embryo Implantation , Embryonic Development , Single-Cell Analysis/methods , Transcriptome , Uterus/physiology , Animals , Blastocyst/cytology , Female , Male , Mice , Signal Transduction , Uterus/cytology
11.
PLoS Comput Biol ; 17(5): e1008976, 2021 05.
Article in English | MEDLINE | ID: mdl-33945541

ABSTRACT

Analyses of gene set differential coexpression may shed light on molecular mechanisms underlying phenotypes and diseases. However, differential coexpression analyses of conceptually similar individual studies are often inconsistent and underpowered to provide definitive results. Researchers can greatly benefit from an open-source application facilitating the aggregation of evidence of differential coexpression across studies and the estimation of more robust common effects. We developed Meta Gene Set Coexpression Analysis (MetaGSCA), an analytical tool to systematically assess differential coexpression of an a priori defined gene set by aggregating evidence across studies to provide a definitive result. In the kernel, a nonparametric approach that accounts for the gene-gene correlation structure is used to test whether the gene set is differentially coexpressed between two comparative conditions, from which a permutation test p-statistic is computed for each individual study. A meta-analysis is then performed to combine individual study results with one of two options: a random-intercept logistic regression model or the inverse variance method. We demonstrated MetaGSCA in case studies investigating two human diseases and identified pathways highly relevant to each disease across studies. We further applied MetaGSCA in a pan-cancer analysis with hundreds of major cellular pathways in 11 cancer types. The results indicated that a majority of the pathways identified were dysregulated in the pan-cancer scenario, many of which have been previously reported in the cancer literature. Our analysis with randomly generated gene sets showed excellent specificity, indicating that the significant pathways/gene sets identified by MetaGSCA are unlikely false positives. MetaGSCA is a user-friendly tool implemented in both forms of a Web-based application and an R package "MetaGSCA". It enables comprehensive meta-analyses of gene set differential coexpression data, with an optional module of post hoc pathway crosstalk network analysis to identify and visualize pathways having similar coexpression profiles.


Subject(s)
Gene Expression Regulation , Algorithms , Computational Biology/methods , Gene Regulatory Networks , Humans , Neoplasms/genetics
12.
Nat Protoc ; 16(4): 2190-2212, 2021 04.
Article in English | MEDLINE | ID: mdl-33731963

ABSTRACT

UV radiation may lead to melanoma and nonmelanoma skin cancers by causing helix-distorting DNA damage such as cyclobutane pyrimidine dimers (CPDs). These DNA lesions, if located in important genes and not repaired promptly, are mutagenic and may eventually result in carcinogenesis. Examining CPD formation and repair processes across the genome can shed light on the mutagenesis mechanisms associated with UV damage in relevant cancers. We recently developed CPD-Seq, a high-throughput and single-nucleotide resolution sequencing technique that can specifically capture UV-induced CPD lesions across the genome. This novel technique has been increasingly used in studies of UV damage and can be adapted to sequence other clinically relevant DNA lesions. Although the library preparation protocol has been established, a systematic protocol to analyze CPD-Seq data has not been described yet. To streamline the various general or specific analysis steps, we developed a protocol named CPDSeqer to assist researchers with CPD-Seq data processing. CPDSeqer can accommodate both a single- and multiple-sample experimental design, and it allows both genome-wide analyses and regional scrutiny (such as of suspected UV damage hotspots). The runtime of CPDSeqer scales with raw data size and takes roughly 4 h per sample with the possibility of acceleration by parallel computing. Various guiding graphics are generated to help diagnose the performance of the experiment and inform regional enrichment of CPD formation. UV damage comparison analyses are set forth in three analysis scenarios, and the resulting HTML pages report damage directional trends and statistical significance. CPDSeqer can be accessed at https://github.com/shengqh/cpdseqer .


Subject(s)
Pyrimidine Dimers/genetics , Sequence Analysis, DNA/methods , Databases, Genetic , Gene Expression Regulation , Genome , Humans , Nucleosomes/metabolism , Quality Control , Ultraviolet Rays
13.
Biol Reprod ; 104(3): 539-547, 2021 03 11.
Article in English | MEDLINE | ID: mdl-33284968

ABSTRACT

The endometrium undergoes a pregnancy-delivery-repair cycle multiple times during the reproductive lifespan in females. Decidualization is one of the critical events for the success of this essential process. We have previously reported that Notch1 is essential for artificial decidualization in mice. However, in a natural pregnancy, the deletion of Notch1 (PgrCre/+Notch1f/f, or Notch1d/d) only affects female fertility in the first 30 days of a 6-month fertility test, but not the later stages. In the present study, we undertook a closer evaluation at the first pregnancy of these mice to attempt to understand this puzzling phenomenon. We observed a large number of pregnancy losses in Notch1d/d mice in their first pregnancy, which led to the subfertility observed in the first 30 days of the fertility test. We then demonstrated that the initial pregnancy loss is a consequence of impaired decidualization. Furthermore, we identified a group of genes that contribute to Notch1 regulated decidualization in a natural pregnancy. Gene ontogeny analysis showed that these differentially expressed genes in the natural pregnancy are involved in cell-cell and cell-matrix interactions, different from genes that have been previously identified from the artificial decidualization model, which contribute to cell proliferation and apoptosis. In summary, we determined that Notch1 is essential for normal decidualization in the mouse uterus only in the first pregnancy but not in subsequent ones.


Subject(s)
Decidua/physiology , Gene Expression Regulation/physiology , Pregnancy, Animal , Receptor, Notch1/metabolism , Abortion, Veterinary/genetics , Animals , Cell Proliferation , Embryo Implantation/genetics , Female , Mice , Mice, Knockout , Pregnancy , Pregnancy, Animal/genetics , Pregnancy, Animal/metabolism , Receptor, Notch1/genetics , Signal Transduction , Transcriptome
14.
Reprod Sci ; 28(1): 60-68, 2021 01.
Article in English | MEDLINE | ID: mdl-32651899

ABSTRACT

It has been well established that uterine function during the peri-implantation period is precisely regulated by ovarian estrogen and progesterone. The embryo enters the uterine cavity before implantation. However, the impact of pre-implantation embryo on uterine function is largely unknown. In the present study, we performed RNA-seq analysis of mouse uterus on day 4 morning of natural pregnancy (with embryos in the uterus) and pseudo-pregnancy (without embryos in the uterus). We found that 146 genes were upregulated, and 77 genes were downregulated by the pre-implantation embryo. Gene ontology and gene network analysis highlighted the activation of inflammatory reaction in the uterus. By examining the promoter region of differentially expressed genes, we found that NF-kappaB was a causal transcription factor. Finally, we validated 4 inflammation-related genes by quantitative RT-PCR. These 4 genes are likely the main mediators of the inflammatory reaction in the uterus triggered by the pre-implantation embryo. Our data indicated that the pre-implantation embryo causes uterine inflammatory reaction, which in turn might contribute to the establishment of uterine receptivity and embryo implantation.


Subject(s)
Blastocyst/metabolism , Embryo Implantation , Inflammation Mediators/metabolism , NF-kappa B/metabolism , Uterus/metabolism , Animals , Blastocyst/immunology , Chemokines, CXC/genetics , Chemokines, CXC/metabolism , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Female , Gene Regulatory Networks , Interleukins/genetics , Interleukins/metabolism , Mice , NF-kappa B/genetics , Pregnancy , Pseudopregnancy/genetics , Pseudopregnancy/immunology , Pseudopregnancy/metabolism , RNA-Seq , Uterus/immunology
15.
Entropy (Basel) ; 22(7)2020 Jul 17.
Article in English | MEDLINE | ID: mdl-33286550

ABSTRACT

Based on a logistic map and Feigenbaum map, we proposed a logistic Feigenbaum non-linear cross-coupled hyperchaotic map (LF-NCHM) model. Experimental verification showed that the system is a hyperchaotic system. Compared with the existing cross-coupled mapping, LF-NCHM demonstrated a wider hyperchaotic range, better ergodicity and richer dynamic behavior. A hyperchaotic sequence with the same number of image pixels was generated by LF-NCHM, and a novel image-encryption algorithm with permutation that is dynamically related to plaintext pixels was proposed. In the scrambling stage, the position of the first scrambled pixel was related to the sum of the plaintext pixel values, and the positions of the remaining scrambled pixels were related to the pixel values after the previous scrambling. The scrambling operation also had a certain diffusion effect. In the diffusion phase, using the same chaotic sequence as in the scrambling stage increased the usage rate of the hyperchaotic sequence and improved the calculation efficiency of the algorithm. A large number of experimental simulations and cryptanalyses were performed, and the results proved that the algorithm had outstanding security and extremely high encryption efficiency. In addition, LF-NCHM could effectively resist statistical analysis attacks, differential attacks and chosen-plaintext attacks.

16.
Genes (Basel) ; 11(8)2020 08 13.
Article in English | MEDLINE | ID: mdl-32823685

ABSTRACT

The mouse is widely used to study decidualization and there are three well-established mouse models of decidualization, namely natural pregnancy decidualization (NPD), artificial decidualization (AD), and in vitro decidualization (IVD). However, the extent of similarity and difference between these models at the molecular level remains largely unknown. Here, we performed a comparative analysis using the RNA-seq approach. In the NPD model, which is thought to be the golden standard of mouse decidualization, we found a total of 5277 differentially expressed genes, with 3158 genes being up-regulated and 2119 genes being down-regulated. A total of 4294 differentially expressed genes were identified in the AD model: 1127 up-regulated genes and 3167 down-regulated genes. In comparison to NPD, 1977 genes were consistently expressed, whereas only 217 genes were inconsistently expressed, indicating that AD is a reliable model for mouse decidualization. In the IVD model, RNA-seq analysis revealed that 513 genes were up-regulated and 988 genes were down-regulated. Compared to NPD, 310 genes were consistently expressed, whereas 456 genes were inconsistently expressed. Moreover, although the decidualization marker Prl8a2 (prolactin family 8 subfamily a member 2) was up-regulated, the widely-used marker Alpl (alkaline phosphatase liver/bone/kidney) was down-regulated in the IVD model. Therefore, we suggest that the IVD model should be optimized to mimic NPD at the transcriptomic level. Our study contributes to an increase in the knowledge about mouse models of decidualization.


Subject(s)
Biomarkers , Decidua/physiology , Estrous Cycle , Animals , Cluster Analysis , Computational Biology/methods , Estrous Cycle/genetics , Female , Gene Expression Profiling , Gene Expression Regulation , Gene Ontology , Mice , Molecular Sequence Annotation , Pregnancy , Reproducibility of Results , Transcriptome
17.
ACS Med Chem Lett ; 11(8): 1611-1619, 2020 Aug 13.
Article in English | MEDLINE | ID: mdl-32832031

ABSTRACT

Mimicking different pharmacophoric units into one scaffold is a promising structural modification tool to design new drugs with enhanced biological properties. To continue our research on the tubulin inhibitors, the synthesis and biological evaluation of arylpyridine derivatives (9-29) are described herein. Among these compounds, 6-arylpyridines (13-23) bearing benzo[d]imidazole side chains at the 2-position of pyridine ring displayed selective antiproliferative activities against HT-29 cells. More interestingly, 2-trimethoxyphenylpyridines 25, 27, and 29 bearing benzo[d]imidazole and benzo[d]oxazole side chains displayed more broad-spectrum antitumor activities against all tested cancer cell lines. 29 bearing a 6-methoxybenzo[d]oxazole group exhibited comparable activities against A549 and U251 cells to combretastatin A-4 (CA-4) and lower cytotoxicities than CA-4 and 5-Fu. Further investigations revealed 29 displays strong tubulin polymerization inhibitory activity (IC50 = 2.1 µM) and effectively binds at the colchicine binding site and arrests the cell cycle of A549 in the G2/M phase by disrupting the microtubules network.

18.
Polymers (Basel) ; 12(1)2020 Jan 09.
Article in English | MEDLINE | ID: mdl-31936639

ABSTRACT

In this study, paraffin was selected as the phase change material (PCM) and high-density polyethylene (HDPE) as the supporting material to prepare a flame-retardant PCM system. The system consisted of paraffin, HDPE, expanded graphite (EG), magnesium hydroxide (MH) and aluminum hydroxide (ATH). The thermal stability and flame retardancy were studied by thermo-gravimetric analysis (TGA), scanning electron microscopy (SEM) and cone calorimeter test (CONE). The SEM proved that the addition of MH and ATH can produce an oxide film on the surface of the composite material and form a "physical barrier" with the char layer, generated by the expansion of EG, preventing the transfer of heat and oxygen. The TGA test showed that, compared with other flame-retardant systems, the materials with added MH and ATH have a higher thermal stability and carbonization ability, and the amount of char residue has increased from 17.6% to 32.9%, which reduces the fire risk of the material. The flame retardant effect is obvious. In addition, the addition of MH and ATH has no significant effect on the phase transition temperature and latent heat value of PCMs. The CONE data further confirmed that MH and ATH can work with EG to prevent heat release, reduce the total heat release rate (THR) value and effectively suppress the generation of smoke, CO and CO2. The peak heat release rate (PHRR) value also decreased, from 1570.2 kW/m2 to 655.9 kW/m2.

19.
J Phys Chem Lett ; 11(3): 905-912, 2020 Feb 06.
Article in English | MEDLINE | ID: mdl-31951138

ABSTRACT

Conversion-type anodes with high theoretical capacity have attracted enormous interest for lithium storage, although their extremely poor conductivity and volume variations during lithiation-delithiation processes seriously limit their practical applications. Herein, a facile strategy to fabricate ZnO/ZnS@N-C heterostructures decorated on carbon nanotubes (ZnO/ZnS@N-C/CNTs) with metal-organic framework assistance is developed. The as-prepared anodes display higher reversible capacity of 1020.6 mAh g-1 at 100 mA g-1 after 200 cycles and excellent high-cyclability with 386.6 mAh g-1 at 1000 mA g-1 over 400 cycles. The conductive CNT network and N-doped carbon shell could successfully improve the electrical conductivity and avoid the aggregation of ultrasmall ZnO/ZnS nanoparticles. The results calculated from density functional theory also suggest that the ZnO/ZnS heterostructures could promote electron-transfer capability.

20.
RNA Biol ; 17(11): 1666-1673, 2020 11.
Article in English | MEDLINE | ID: mdl-31607216

ABSTRACT

Non-coding RNAs occupy a significant fraction of the human genome. Their biological significance is backed up by a plethora of emerging evidence. One of the most robust approaches to demonstrate non-coding RNA's biological relevance is through their prognostic value. Using the rich gene expression data from The Cancer Genome Altas (TCGA), we designed Advanced Expression Survival Analysis (AESA), a web tool which provides several novel survival analysis approaches not offered by previous tools. In addition to the common single-gene approach, AESA computes the gene expression composite score of a set of genes for survival analysis and utilizes permutation test or cross-validation to assess the significance of log-rank statistic and the degree of over-fitting. AESA offers survival feature selection with post-selection inference and utilizes expanded TCGA clinical data including overall, disease-specific, disease-free, and progression-free survival information. Users can analyse either protein-coding or non-coding regions of the transcriptome. We demonstrated the effectiveness of AESA using several empirical examples. Our analyses showed that non-coding RNAs perform as well as messenger RNAs in predicting survival of cancer patients. These results reinforce the potential prognostic value of non-coding RNAs. AESA is developed as a module in the freely accessible analysis suite MutEx. Abbreviation: ACC: Adrenocortical Carcinoma (n = 92); BLCA: Bladder Urothelial Carcinoma (n = 412); BRCA: Breast Invasive Carcinoma (n = 1098); CESC: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (n = 307); CHOL: Cholangiocarcinoma (n = 51); COAD: Colon Adenocarcinoma (n = 461); DLBC: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (n = 58); ESCA: Oesophageal Carcinoma (n = 185); GBM: Glioblastoma Multiforme (n = 617); HNSC: Head and Neck Squamous Cell Carcinoma (n = 528); KICH: Kidney Chromophobe (n = 113); KIRC: Kidney Renal Clear Cell Carcinoma (n = 537); KIRP: Kidney Renal Papillary Cell Carcinoma (n = 291); LAML: Acute Myeloid Leukaemia (n = 200); LGG: Brain Lower Grade Glioma (n = 516); LIHC: Liver Hepatocellular Carcinoma (n = 377); LUAD: Lung Adenocarcinoma (n = 585); LUSC: Lung Squamous Cell Carcinoma (n = 504); MESO: Mesothelioma (n = 87); OV: Ovarian Serous Cystadenocarcinoma (n = 608) PAAD: Pancreatic Adenocarcinoma (n = 185); PCPG: Pheochromocytoma and Paraganglioma (n = 179); PRAD: Prostate Adenocarcinoma (n = 500); READ: Rectum Adenocarcinoma (n = 172); SARC: Sarcoma (n = 261); SKCM: Skin Cutaneous Melanoma (n = 470); STAD: Stomach Adenocarcinoma (n = 443); TGCT: Testicular Germ Cell Tumours (n = 150); THCA: Thyroid Carcinoma (n = 507) THYM: Thymoma (n = 124); UCEC: Uterine Corpus Endometrial Carcinoma (n = 560); UCS: Uterine Carcinosarcoma (n = 57); UVM: Uveal Melanoma (n = 80).


Subject(s)
Biomarkers, Tumor , Gene Expression Regulation, Neoplastic , Neoplasms/genetics , Neoplasms/mortality , RNA, Untranslated/genetics , Computational Biology/methods , Databases, Genetic , Gene Expression Profiling , Humans , Prognosis , RNA, Long Noncoding/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...